October 1, 2025 - 08:45

In a significant achievement for renewable energy innovation, ODQA and KTH have been jointly awarded the prestigious SolarPACES Technology Innovation Award 2025. The award recognizes their groundbreaking work on the High-Temperature Air-Based Integrated Concentrated Solar Technology (CST), designed to deliver flexible renewable heat solutions for industrial applications.
The award ceremony featured representatives from both organizations, including Pok Wan Kwang and Gediz Karaca from ODQA, alongside Rafael Guedez, Silvia Trevisan, and Konstantinos Apostolopoulos-Kalkavouras from KTH. Their collaborative efforts highlight the potential of advanced solar technologies to meet the growing demand for sustainable heat in various industries.
The innovative CST system developed by the team is poised to revolutionize the way heat is generated and utilized, offering a cleaner and more efficient alternative to traditional fossil fuels. This recognition not only underscores the importance of research and development in renewable energy but also sets a benchmark for future innovations in the field.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...